All Peptide

SS-31, also known as Elamipretide, is a synthetic mitochondria-targeted tetrapeptide designed to support mitochondrial function. It selectively associates with cardiolipin, a phospholipid unique to the inner mitochondrial membrane, and has been studied for its ability to stabilize mitochondrial structure, reduce oxidative stress, and influence ATP production. Research interest has focused on its role in models of aging, mitochondrial biology, and organ function

Epitalon (also called Epithalamin) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) originally developed from research on pineal gland extracts. It has been investigated for its potential to influence telomerase activity, circadian rhythm regulation, and cellular processes related to aging. Epitalon has become a subject of interest in longevity research and peptide bioregulation.

Follistatin is a naturally occurring glycoprotein encoded by the FST gene, recognized for its ability to bind and neutralize members of the TGF-β superfamily, particularly myostatin (GDF-8). By regulating these pathways, Follistatin has become a key subject of research in muscle biology, fibrosis control, reproductive endocrinology, and regenerative medicine.

FOXO4-DRI (FOXO4-D-Retro-Inverso) is a synthetic peptide designed to selectively interfere with the interaction between the transcription factor FOXO4 and p53. By mimicking a functional region of FOXO4, it has been studied as a potential senolytic agent, aiming to support the clearance of senescent cells while sparing healthy ones. Research into FOXO4-DRI focuses on its role in aging biology, regenerative science, and cell-fate modulation.

GDF-8, also known as myostatin, is a member of the transforming growth factor-beta (TGF-β) superfamily of proteins. It functions as a negative regulator of skeletal muscle growth, limiting muscle cell proliferation and differentiation. GDF-8 is primarily expressed in skeletal muscle and has become an important focus of basic and translational research in muscle physiology.

GHK-Cu (Glycyl-L-histidyl-L-lysine-Copper) is a naturally occurring copper-binding tripeptide found in human plasma, saliva, and urine. It has been studied for its role in tissue remodeling, antioxidant defense, and support of extracellular matrix regulation. By binding copper (Cu²⁺), GHK-Cu may provide bioavailable copper for enzymatic processes relevant to collagen formation and cellular protection.

GHRP-6 (Growth Hormone Releasing Peptide-6) is a synthetic hexapeptide studied for its ability to stimulate growth hormone (GH) release by binding to the ghrelin receptor (GHS-R1a). As part of the GHRP family, GHRP-6 is primarily investigated in research for its roles in GH axis modulation, appetite signaling, anabolic pathways, and recovery mechanisms. It is also noted for its pronounced ghrelin-mimetic activity influencing hunger and gastric motility.

Gonadorelin Acetate is a synthetic decapeptide analog of gonadotropin-releasing hormone (GnRH). It is studied for its ability to regulate the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the anterior pituitary, thereby influencing the hypothalamic-pituitary-gonadal (HPG) axis. As a bioidentical form of human GnRH, Gonadorelin Acetate is widely used in research and diagnostics involving reproductive endocrinology, hormone axis function, and pulsatile GnRH signaling.

Hexarelin Acetate is a synthetic hexapeptide classified as a growth hormone-releasing peptide (GHRP). It binds to the ghrelin receptor (GHSR-1a), stimulating growth hormone (GH) secretion in a pulsatile manner. Compared to other GHRPs such as GHRP-2 and GHRP-6, Hexarelin is noted for its stronger potency and longer half-life, making it a valuable research tool in the study of GH regulation, metabolic function, and cardiovascular protection.

IGF-1 LR3 (Long R3 Insulin-like Growth Factor-1) is a synthetic analog of human insulin-like growth factor 1 (IGF-1), engineered for greater stability and bioavailability. It differs from native IGF-1 by containing a 13–amino-acid N-terminal extension and a substitution of arginine for glutamic acid at position 3. These modifications reduce binding to IGF-binding proteins (IGFBPs), prolonging its half-life and enhancing biological potency. IGF-1 LR3 is widely studied in the fields of musculoskeletal regeneration, tissue repair, neuroprotection, and metabolic regulation.